期刊文献+

MiR-133a-3p在膀胱癌中的表达及其分子机制研究

Expression of MiR-133a-3p in Bladder Cancer and its Molecular Mechanism
下载PDF
导出
摘要 目的:利用生物信息学方法研究miR-133a-3p在膀胱癌组织中的表达和临床意义,并鉴定其靶基因和信号通路。方法:来自多个公共高通量数据库的514例膀胱癌组织和78例非癌组织样本用于评估miR-133a-3p的表达水平和临床意义。MiR-133a-3p的靶基因用于检测与膀胱癌进展相关的信号通路及其枢纽基因,并进一步验证枢纽基因与miR-133a-3p的相关性。结果:与非癌组织相比,miR-133a-3p在膀胱癌组织中表达显著下调(SMD=-1.604,p=0.015),且对膀胱癌具有鉴别意义(AUC=0.910,95%CI:0.880至0.930),miR-133a-3p高表达的膀胱癌患者预后相对较差(HR=1.383,p=0.030)。不同的患病年龄(t=2.414,p=0.0162)、疾病分期(T分期:t=2.488,p=0.0133;N分期:t=3.153,p=0.0017)、病理等级(t=2.067,p=0.0393)、肿瘤亚型(t=3.118,p=0.0048)的膀胱癌患者之间,其miR-133a-3p表达水平存在显著差异。富集分析结果表明miR-133a-3p的靶基因通过癌症、胞吞、Rap1等信号通路在膀胱癌中发挥影响。通过蛋白互作网络共筛选出9个枢纽基因(EGFR、CLTA、ARPC5、TFRC、NUDT21、FPR3、LAMC1、GNAI3、CAP1),其中CLTA、TFRC、NUDT21、CAP1与miR-133a-3p呈显著负相关。结论:miR-133a-3p在膀胱癌中表达下调且对膀胱癌具有良好的鉴别、预后价值,它可通过多种信号途径影响膀胱癌的进程。 Objective:Using bioinformatics techniques,it is our goal to investigate miR-133a-3p expression in bladder cancer tissues and its clinical relevance,as well as to pinpoint its target genes and signaling pathways.Methods:The expression level and clinical value of miR-133a-3p were assessed using 514 bladder cancer tissue samples and 78 non-cancer tissue samples from various public high-throughput databases.The signaling pathways associated with the progression of bladder cancer and hub genes were found using the miR-133a-3p target genes,and this further confirmed the association between hub genes and miR-133a-3p.Results:In bladder cancer tissues compared to non-cancerous tissues,miR-133a-3p expression was significantly downregulated(SMD=-1.604,p=0.015),and it was significant for diagnosing bladder cancer(AUC=0.910,95%CI:0.880 to 0.930),bladder cancer patients with high expression of miR-133a-3p had a relatively poor prognosis(HR=1.383,p=0.030).Different age at disease(t=2.414,p=0.0162),disease stage(T stage:t=2.488,p=0.0133;N stage:t=3.153,p=0.0017),pathological grade(t=2.067,p=0.0393)and tumor subtypes(t=3.118,p=0.0048),the expression levels of miR-133a-3p were significantly different.The pathway results demonstrated that miR-133a-3p target genes were functionally enriched in the pathways of“cancer cell apoptosis,”“cadherin-bound cell adhesion”and“cytoskeleton formation.”Protein interaction network was used to screen a total of 9 hub genes(EGFR,CLTA,ARPC5,TFRC,NUDT21,FPR3,LAMC1,GNAI3,CAP1),of which CLTA,TFRC,NUDT21,and CAP1 had significantly negative correlations with miR-133a-3p.Conclusion:MiR-133a-3p,a reliable marker and prognostic factor for the disease,is downregulated in bladder cancer.It can affect the progression of bladder cancer through various signaling pathways.
作者 刘加林 翟高强 黄志广 莫曾南 程继文 李生华 Jialin Liu;Gaoqiang Zhai;Zhiguang Huang;Zengnan Mo;Jiwen Cheng;Shenghua Li(Department of Urology,First Affiliated Hospital of Guangxi Medical University,Nanning Guangxi,530021,China;Department of Pathology,First Affiliated Hospital of Guangxi Medical University,Nanning,Guangxi,530021,China)
出处 《生物工程前沿(中英文版)》 2022年第1期34-41,共8页 Biotechnology Frontier
基金 广西自然科学基金(项目编号:2018GXNSFAA281175) 广西泌尿系统疾病临床医学研究中心资助课题(项目编号:2020AC03006) 广西壮族自治区卫生和计划生育委员会科研课题(项目编号:Z20200963)。
关键词 MiR-133a-3p 膀胱癌 差异表达 预后 富集分析 枢纽基因 MiR-133a-3p Bladder Cancer Differential Expression Prognosis Enrichment Analysis Hub Genes
  • 相关文献

参考文献1

二级参考文献4

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部